Fortress Biotech, Inc.
FBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $57,675 | $84,513 | $75,743 | $68,791 |
| % Growth | -31.8% | 11.6% | 10.1% | – |
| Cost of Goods Sold | $20,879 | $22,893 | $30,775 | $32,084 |
| Gross Profit | $36,796 | $61,620 | $44,968 | $36,707 |
| % Margin | 63.8% | 72.9% | 59.4% | 53.4% |
| R&D Expenses | $56,881 | $106,071 | $134,876 | $128,865 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $87,731 | $90,981 | $113,656 | $86,843 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,563 | $6,910 | $0 | $9,540 |
| Operating Expenses | $147,175 | $203,962 | $248,532 | $225,248 |
| Operating Income | -$110,379 | -$142,342 | -$203,564 | -$188,541 |
| % Margin | -191.4% | -168.4% | -268.8% | -274.1% |
| Other Income/Exp. Net | -$10,164 | -$11,291 | -$9,900 | $24,188 |
| Pre-Tax Income | -$120,543 | -$153,633 | -$213,464 | -$164,353 |
| Tax Expense | $312 | $521 | $449 | $473 |
| Net Income | -$45,997 | -$60,637 | -$86,575 | -$64,703 |
| % Margin | -79.8% | -71.7% | -114.3% | -94.1% |
| EPS | -2.69 | -8.47 | -14.55 | -11.85 |
| % Growth | 68.2% | 41.8% | -22.8% | – |
| EPS Diluted | -2.69 | -8.47 | -14.55 | -11.85 |
| Weighted Avg Shares Out | 20,784 | 8,111 | 5,925 | 5,447 |
| Weighted Avg Shares Out Dil | 20,784 | 8,111 | 5,925 | 5,447 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,683 | $3,003 | $1,398 | $649 |
| Interest Expense | $9,927 | $12,519 | $13,642 | $15,308 |
| Depreciation & Amortization | $4,464 | $5,997 | $9,353 | $6,791 |
| EBITDA | -$104,491 | -$135,721 | -$193,694 | -$146,168 |
| % Margin | -181.2% | -160.6% | -255.7% | -212.5% |